B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

NCT01049633 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

NIH

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

BIOLOGICAL: Allogeneic Pancreatic Islet Cells
DRUG: Sirolimus
BIOLOGICAL: Basiliximab
DRUG: Tacrolimus
DRUG: Antibacterial, Antifungal, and Antiviral Prophylaxis
DRUG: Trimethoprim/sulfamethoxazole
DRUG: Clotrimazole
DRUG: Valganciclovir
DRUG: Heparin
DRUG: Enoxaparin
DRUG: Pentoxifylline
DRUG: Aspirin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]